ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹9.31 Cr | ₹5.36 Cr | ₹5.43 Cr | ₹13 Cr | ₹11 Cr |
What is the latest Contingent Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹9.31 Cr |
| Mar2024 | ₹5.36 Cr |
| Mar2023 | ₹5.43 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹11 Cr |
How is Contingent Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.31 Cr | 73.70 | |
| Mar2024 | ₹5.36 Cr | -1.40 | |
| Mar2023 | ₹5.43 Cr | -58.47 | |
| Mar2022 | ₹13 Cr | 15.98 | |
| Mar2021 | ₹11 Cr | - | |
Compare Contingent Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,305.5 Cr | -4.4% | 8.4% | 6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -4.4% |
8.4% |
6.5% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses